jcc
10-23-2006, 06:11 PM
I found this to be an interesting commentary. This was a small opinion type article in regard to the development of new treatments for celiac disease (treatment other than GFD). The lead up was a general description of celiac disease and the challenges of a GFD. Thanks, Anne ;).
For these reasons, there is considerable
interest in the development of alternative
therapies.2 However, GFD remains the only
treatment that does not involve drugs, side
effects, or long term risks, and has an almost
100% success rate, and so any ‘‘better than
GFD’’ therapy should therefore not only
allow gluten ingestion without stimulating
an immunological response but also have no
side effects, no long term risks, and be highly
effective and cheap. This is a very difficult
goal and poses ethical problems for future
trials.
Coeliac disease: between "pizza" and ethics. (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17047123&query_hl=9&itool=pubmed_docsum)
Gut. 2006 Nov;55(11):1672. No abstract available.
PMID: 17047123
For these reasons, there is considerable
interest in the development of alternative
therapies.2 However, GFD remains the only
treatment that does not involve drugs, side
effects, or long term risks, and has an almost
100% success rate, and so any ‘‘better than
GFD’’ therapy should therefore not only
allow gluten ingestion without stimulating
an immunological response but also have no
side effects, no long term risks, and be highly
effective and cheap. This is a very difficult
goal and poses ethical problems for future
trials.
Coeliac disease: between "pizza" and ethics. (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17047123&query_hl=9&itool=pubmed_docsum)
Gut. 2006 Nov;55(11):1672. No abstract available.
PMID: 17047123